Skip to content

ANTARCTICA trial: Cryo-thawed embryo transfer: natural versus artificial cycle. A non inferiority trial.

Cryo-thawed embryo transfer: natural versus artificial cycle. A non inferiority trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25356
Enrollment
1150
Registered
2009-01-13
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EN: subfertility, cryo thawed embryo transfer, IVF NL: subfertiliteit, gecryopreserveerder embryo's, IVF

Interventions

Cryo thawed embryo transfer in natural cycle versus artificial cycle.

Sponsors

Isala Klinieken dr. BJ Cohlen & drs. ER Groenewoud Postbus 10400 8000 GK Zwolle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18 en 40, planning to receive a frozen thawed embryo transfer, embryos orginated out of IVF/ICSI treatment 1,2 or 3. 2. Patients are willing to participate during 1 frozen thawed embryo transfer treatment cycle and are willing to sign informed consent. 3. Ovulatoir menstruationcycle between 26 and 35 days.

Exclusion criteria

Exclusion criteria: Patients with a contraindication for medication used in this study such as: 1. Trombo-embolic event in the patients history; 2. Severe disorder of liverfunction; 3. Estrogen sensitive tumors; 4. Breastcancer; 5. Porfyria; 6. Patients with a known allergy for one of the used medicines; 7. Patients with anovulatory menstruation cycles; 8. Patients with uterine abnormalities; 9. Patients with cryo embryos derrived from oocyte donation.

Design outcomes

Primary

MeasureTime frame
Live birth rate.

Secondary

MeasureTime frame
1. Clinical pregnancy, ongoing pregnancy, cancellation rates (per started cryo cycle). 2. Endometrial growth. 3. Cost efficiancy and analyses of the burden of treatment. 4. SAE.

Contacts

Public ContactE.R. Groenewoud

Postbus 10400

e.r.groenewoud@isala.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)